{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:58:07Z","timestamp":1790927887091,"version":"4.1.0"},"reference-count":43,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100000380","name":"Guy's & St Thomas' Foundation","doi-asserted-by":"publisher","award":["EIC180702"],"award-info":[{"award-number":["EIC180702"]}],"id":[{"id":"10.13039\/501100000380","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W024454\/1"],"award-info":[{"award-number":["MR\/W024454\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR205287"],"award-info":[{"award-number":["NIHR205287"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023233","name":"National Institute for Health and Care Research Applied Research Collaboration Oxford and Thames Valley","doi-asserted-by":"publisher","award":["NIHR200172"],"award-info":[{"award-number":["NIHR200172"]}],"id":[{"id":"10.13039\/501100023233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["CL\u20102022\u201313\u2013005"],"award-info":[{"award-number":["CL\u20102022\u201313\u2013005"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>It remains unclear which cardiovascular disease (CVD) risk scores are optimized for people living with treated HIV with high rates of viral suppression. We evaluated the performance of commonly used CVD risk scores in a population of primarily well\u2010treated HIV patients in England.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A multi\u2010centre retrospective cohort analysis was performed, including people living with HIV (PLWH) above the age of 40 with no prior major adverse CVD events (MACE), regularly attending 7 HIV clinics in England during 2014. Outcomes were MACE over the following 5\u2009years: myocardial infarction, invasive cardiac procedure e.g. primary angioplasty, cerebrovascular events, new heart failure, and CVD\u2010related death. Clinical outcomes were aligned with the respective risk scores. The following CVD risk models were evaluated: the UK primary\u2010care validated QRISK3, Framingham laboratory and non\u2010laboratory (Office) scores, Data collection on Adverse events of anti\u2010HIV Drugs (D:A:D), Pooled Cohort Equation (PCE), and the World Health Organization (WHO) laboratory and non\u2010laboratory models. Models were scaled for 5\u2010year CVD estimates. We assessed the discrimination and calibration of these 5\u2010year models within our population. Multiple imputation was used to address missing data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 2582 people, 94 had at least one MACE documented during follow\u2010up. All seven scores demonstrated moderate discrimination. QRISK3 demonstrated the best calibration in this cohort with an O:E ratio of 1.169, 95% CI 0.950, 1.439, mean calibration\u2010in\u2010the\u2010large (CITL) value of 0.156 (95% CI \u22120.052, 0.364) and slope of 0.897 (0.682, 1.113). Framingham Office generally overpredicted risk, while WHO scores and D:A:D generally underpredicted risk. Imputing for missing data yielded results similar to the complete case analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CVD risk scores demonstrated moderate performance in a well\u2010treated PLWH cohort. Our findings emphasize the need to calibrate each CVD risk score to the local population to guide prioritization of clinical resources for CVD prevention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Evidence in Context<\/jats:title>\n                    <jats:p>Evidence before this study: We systematically searched Medline, Embase, and Cochrane Library database from January 1995 to August 2023, using the following terms \u2018HIV\/AIDS and Cardiovascular Disease (CVD) outcomes\u2019, with an updated search to 2025. The risk of CVD has been reported to be up to two times that of people living without HIV, along with increased rates of heart failure and sudden death. Commonly used CVD risk scores have demonstrated variable performance for PLWH, and only the D:A:D study equation has been specifically validated in an HIV\u2010positive population. Within an era of modern ART regimes and high rates of viral suppression, there have been numerous comparisons of CVD risk across scoring systems, but few studies with observed outcomes of CVD rates to validate the predictions. It remains unclear which CVD risk calculator is the most suitable for PLWH. The use of routinely collected clinical data may also impact the accuracy of results due to the presence of incomplete or missing data fields. In this study, we aimed to evaluate the performance of commonly used CVD risk scores in a population of primarily well\u2010treated HIV patients in England using routinely collected clinical data. Added value of this study: We demonstrate that of the seven CVD risk scores evaluated (QRISK3, Framingham laboratory and non\u2010laboratory (Office) scores, D:A:D, Pooled Cohort Equation (PCE), and the WHO laboratory and non\u2010laboratory models), all showed moderate discrimination compared to observed major adverse cardiovascular events (MACE) rates in an English multicentre cohort of people living with HIV attending clinics. QRISK3, using a large UK primary care database to validate predicted CVD risk, appeared to be most closely calibrated to CVD outcomes in our cohort without the need for additional calibration. Our findings also suggest that the use of non\u2010laboratory scores, which have been suggested for low and middle\u2010income settings where laboratory results may not be available, should be interpreted with caution, and further testing may be required due to their miscalibration in this cohort. Implications of all the available evidence: Using real\u2010world clinical data from people with HIV who are engaged in care in England, these findings emphasize the need to calibrate each CVD risk score to the local population it is used for in order to accurately guide prioritization of clinical resources for primary CVD prevention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/hiv.70282","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T01:24:43Z","timestamp":1784597083000},"page":"1629-1641","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A multicentre evaluation of cardiovascular risk prediction tools in people living with\n                    <scp>HIV<\/scp>\n                    across England (\n                    <scp>ECARTH<\/scp>\n                    study)"],"prefix":"10.1111","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5244-0070","authenticated-orcid":false,"given":"Ming Jie","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Infectious Disease Imperial College London  London UK"},{"name":"Harrison Wing, Department of HIV Guy's and St Thomas Hospitals NHS FT  London UK"},{"name":"Canberra Sexual Health Centre  Canberra Australian Capital Territory Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9780-7617","authenticated-orcid":false,"given":"Ashley","family":"Murray","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences University of Oxford  Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette","family":"Smith","sequence":"additional","affiliation":[{"name":"Institute of Global Health University College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakee","family":"Abdi","sequence":"additional","affiliation":[{"name":"Royal Free London NHS FT  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Duncan","sequence":"additional","affiliation":[{"name":"Harrison Wing, Department of HIV Guy's and St Thomas Hospitals NHS FT  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Dwyer","sequence":"additional","affiliation":[{"name":"West Middlesex University Hospital, Chelsea and Westminster Hospital NHS FT  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Gompels","sequence":"additional","affiliation":[{"name":"North Bristol NHS Trust  Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3326-9674","authenticated-orcid":false,"given":"Merle","family":"Henderson","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Imperial College London  London UK"},{"name":"Imperial College Healthcare NHS Trust  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Johnson","sequence":"additional","affiliation":[{"name":"Royal Free London NHS FT  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Lander","sequence":"additional","affiliation":[{"name":"West Middlesex University Hospital, Chelsea and Westminster Hospital NHS FT  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Manmathan","sequence":"additional","affiliation":[{"name":"Royal Free London NHS FT  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Mok","sequence":"additional","affiliation":[{"name":"Harrison Wing, Department of HIV Guy's and St Thomas Hospitals NHS FT  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nnenna","family":"Ngwu","sequence":"additional","affiliation":[{"name":"Royal Free London NHS FT  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coral","family":"Pratt","sequence":"additional","affiliation":[{"name":"North Bristol NHS Trust  Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Reeves","sequence":"additional","affiliation":[{"name":"Homerton University Hospital NHS FT  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razan","family":"Saman","sequence":"additional","affiliation":[{"name":"Imperial College Healthcare NHS Trust  London UK"},{"name":"Leeds Teaching Hospital NHS Trust  Leeds UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Sharp","sequence":"additional","affiliation":[{"name":"Harrison Wing, Department of HIV Guy's and St Thomas Hospitals NHS FT  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Taylor","sequence":"additional","affiliation":[{"name":"Homerton University Hospital NHS FT  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhia Jiat","family":"Teh","sequence":"additional","affiliation":[{"name":"Imperial College Healthcare NHS Trust  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Stevens","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences University of Oxford  Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Fanshawe","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences University of Oxford  Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jienchi","family":"Dorward","sequence":"additional","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences University of Oxford  Oxford UK"},{"name":"Centre for the AIDS Programme of Research in South Africa (CAPRISA) University of KwaZulu\u2010Natal  Durban South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjababu","family":"Kulasegaram","sequence":"additional","affiliation":[{"name":"Harrison Wing, Department of HIV Guy's and St Thomas Hospitals NHS FT  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2756-372X","authenticated-orcid":false,"given":"Anthony S.","family":"Wierzbicki","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine\/Chemical Pathology Guy's and St Thomas Hospitals NHS FT  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/JAMANETWORKOPEN.2020.7954"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352\u20103018(17)30066\u20108"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.AMJCARD.2013.12.036"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.028975"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/JAMACARDIO.2016.4494"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/2047487315579291"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/ARCHINTE.165.10.1179"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.AIDS.0000171410.76607.F8"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/CID\/CIS933"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA062360\/SUPPL_FILE\/NEJM_EL_SADR_2283SA1.PDF"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/INFDIS\/JIQ084"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PMED.0050203"},{"key":"e_1_2_10_14_1","doi-asserted-by":"crossref","unstructured":"Friis\u2010M\u00f8llerN ReissP SabinCA et al.Class of antiretroviral drugs and the risk of myocardial infarction.2007;356(17):1723\u20101735. doi:10.1056\/NEJMOA062744","DOI":"10.1056\/NEJMoa062744"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(08)60423\u20107"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/BPH.14589"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA2304146\/SUPPL_FILE\/NEJMOA2304146_DATA\u2010SHARING.PDF"},{"key":"e_1_2_10_18_1","unstructured":"WatersL GilleeceY AlagaratnamJ et al.BHIVA rapid guidance on the use of statins for primary prevention of cardiovascular disease in people living with HIV (Updated March 2024) [Internet].2024.https:\/\/www.bhiva.org\/BHIVA\u2010rapid\u2010guidance\u2010on\u2010the\u2010use\u2010of\u2010statins\u2010for\u2010primary\u2010prevention\u2010of\u2010cardiovascular\u2010disease"},{"key":"e_1_2_10_19_1","unstructured":"BakerJ GliddenD HyleE et al.Recommendations for the use of statin therapy as primary prevention of atherosclerotic cardiovascular disease in people with HIV [Internet]. Accessed March 18 2024.https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-arv\/statin-therapy-people-hiv"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/INFDIS\/JIS196"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJR.0B013E328336A150"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12300"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/S12879\u2010017\u20102708\u2010Y"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.699579\/SUPPL_FILE\/CI068679.DSTABS.DOC"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000437741.48606.98\/\u2010\/DC1"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/BMJ.J2099"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214\u2010109X(19)30318\u20103"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/JAMA.2014.2630"},{"key":"e_1_2_10_29_1","unstructured":"KaptogeS.Whocvdrisk: Stata module for WHO cardiovascular disease risk prediction.https:\/\/github.com\/skkceu\/stata."},{"key":"e_1_2_10_30_1","unstructured":"R Core Team.R: The R Project for Statistical Computing [Internet].2023. Accessed August 5 2023.https:\/\/www.r-project.org\/"},{"key":"e_1_2_10_31_1","volume-title":"Stata Statistical Software: Release 18","author":"StataCorp","year":"2023"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.18637\/JSS.V045.I03"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1201\/9780429492259"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/9780470316696"},{"key":"e_1_2_10_35_1","unstructured":"LeeM SmithC MokJ DuncanA KulasegaramR WierzbickiA.P170: Comparison between cardiovascular disease risk scores and observed rates of cardiovascular disease in people living with HIV. In: HIV Glasgow 2018.2018."},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/SIM.6787"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000004331"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352\u20103018(24)00276\u20105"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/JAMACARDIO.2022.4873"},{"key":"e_1_2_10_40_1","unstructured":"ARCHIVED CONTENT [Internet]. Accessed September 10 2025.https:\/\/webarchive.nationalarchives.gov.uk\/ukgwa\/20181110211646\/https:\/\/www.gov.uk\/government\/publications\/hiv-in-the-united-kingdom"},{"key":"e_1_2_10_41_1","unstructured":"HIV testing PrEP new HIV diagnoses and care outcomes for people accessing HIV services: 2024 report \u2013 GOV.UK [Internet]. Accessed September 10 2025.https:\/\/www.gov.uk\/government\/statistics\/hiv-annual-data-tables\/hiv-testing-prep-new-hiv-diagnoses-and-care-outcomes-for-people-accessing-hiv-services-2024-report#hiv-care-outcomes"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2666\u20107568(21)00088\u2010X"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1136\/HEARTJNL\u20102022\u2010321231"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/S41591\u2010024\u201002905\u2010Y;SUBJMETA"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hiv.70282","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/hiv.70282","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hiv.70282","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:51:27Z","timestamp":1790927487000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hiv.70282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1111\/hiv.70282"],"URL":"https:\/\/doi.org\/10.1111\/hiv.70282","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"2025-12-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}